Co-Diagnostics, Inc. Net Fee Amt
Co-Diagnostics, Inc. (CODX) had Net Fee Amt of $526.62 as of 2026-08-24, per its S-3 filed 2026-08-24.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-24
- 2026-08-24: Net Fee Amt $526.62.
- 2026-05-28: Net Fee Amt $5.85K.
- 2026-05-12: Net Fee Amt $6.19K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-24 | $526.62 S-3 · filed 2026-08-24 |
| 2026-05-28 | $5.85K S-3 · filed 2026-05-28 |
| 2026-05-12 | $6.19K S-3 · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |